Thank you for your support to accelerate discovery of new oncology therapies for young people treated at Ann & Robert H. Lurie Children's Hospital of Chicago. Your dedication has been essential as we fully implement our Precision Medicine initiative, including the pending hire of a research technician to expedite research and support the talent and resources we have brought to Lurie Children's over the last few months.
Lurie Children's launched its Precision Medicine Initiative in early 2017—an imperative to bring the necessary talent and resources together if we are to find the best therapies that will be most effective against the unique characteristics of each child's cancer. In recent months, we have made considerable progress in this initiative:
As a testament to the growing strength of our research and clinical care, two new globally acclaimed physician-scientists have joined our team. They will provide critical value by developing orthotopic xenograft models (PDX). These orthotopic models are made by taking tumor tissues from patients and implanting them into the anatomic locations in mice reflective of the child's tumor, where they are tested with specific drugs to determine the best course of therapy. This method is difficult to conduct, but produces the most accurate recreation of how tumors in children will respond to drugs.
Your funding will bring a vital link to our oncology team by allowing these transformational initiatives and world-class investigators to speed up research and ultimately bring better therapies to children sooner. I look forward to updating you on our progress as we continue our search for a research technician with the right skill set to partner with these scientists.
Cal’s Angels partners with Lurie Children’s Hospital and Northwestern University Feinberg School of Medicine to create new treatments for children’s cancers and save more children’s lives.
READ MOREI would like to express my appreciation for the support and thoughtfulness Cal’s All-Star Angel Foundation has demonstrated in order to provide brighter futures for children and their families. Your investment is enabling us to obtain the necessary personnel and resources to pursue breakthrough research that will produce increasingly more individualized and effective treatments for our patients.
READ MOREYour support will accelerate our efforts in pediatric drug discovery, making it possible to bring new therapies from the laboratory to human clinical trials in a more efficient and cost-effective way.
READ MORE